You have 9 free searches left this month | for more free features.

apalutamide

Showing 1 - 25 of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 6, 2022

Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

Recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • Apalutamide
  • Cetrelimab
  • San Francisco, California
    University of California, San Francisco
Mar 21, 2022

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

Terminated
  • Prostate Adenocarcinoma
  • Apalutamide
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 28, 2021

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
Aug 2, 2022

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jul 29, 2022

High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)

Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
Aug 2, 2021

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

Active, not recruiting
  • Castration-Resistant Prostate Cancer
  • Apalutamide
  • Greenville, South Carolina
  • +4 more
Aug 2, 2022

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
Aug 3, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,

Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • Apalutamide
  • Stereotactic Body Radiation Therapy
  • San Francisco, California
    University of California, San Francisco
Aug 26, 2021

Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)

Unknown status
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
May 14, 2021

Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)

Completed
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • Salvador, Bahia, Brazil
  • +13 more
Jul 5, 2021

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +4 more
Oct 20, 2021

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • La Jolla, California
  • +3 more
Sep 1, 2021

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Apalutamide
  • Quality-of-Life Assessment
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
Nov 15, 2020

Metastatic Castration-sensitive Prostate Cancer Trial in Osaka-sayama (Apalutamide)

Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Apalutamide
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
Dec 6, 2020

Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

Recruiting
  • Cancer of Prostate
  • Apalutamide
  • +4 more
  • Aalst, Belgium
  • +8 more
Aug 4, 2021

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))

Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
Aug 13, 2020

Healthy Trial in Merksem (Apalutamide)

Completed
  • Healthy
  • Apalutamide
  • Merksem, Belgium
    Clinical Pharmacology Unit
Aug 7, 2020